RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness

43Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neutrophil responses are central to host protection and inflammation. Neutrophil activation follows a 2-stepprocess in which priming amplifies responses to activating stimuli. Priming isessential for life span extension, chemotaxis, and respiratory burst activity. Here we show that the cytoskeletal organizer RhoA suppresses neutro phil priming via formins. Premature granule exocytosis in Rho-deficient neutrophils activated numerous signaling pathways and amplified superoxide generation. Deletion of Rho altered front-to-back coordination by simultaneously increasing uropod elongation, leading edge formation, and random migration. Concomitant negative and positive regulation of β2 integrin-independent and β2 integrin-dependent migration, respectively, reveal Rho as a key decision point in the neutrophil response to discrete chemotactic agents. Although even restricted influx of Rho-deficient hyperactive neutrophils exacerbated lipopolysaccharide-mediated lung injury, deleting Rho in innate immune cells was highly protective in influenza A virus infection. Hence, Rho is a key regulator of disease progression by maintaining neutrophil quiescence and suppressing hyperresponsiveness. © 2014 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Jennings, R. T., Strengert, M., Hayes, P., El-Benna, J., Brakebusch, C., Kubica, M., & Knaus, U. G. (2014). RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness. Blood, 123(23), 3635–3645. https://doi.org/10.1182/blood-2014-02-557843

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free